Dr. Mahavir Agarwal is a Psychiatrist and Scientist in the Schizophrenia Division at the Centre for Addiction at Mental Health (CAMH), Toronto and an Associate Professor in the Department of Psychiatry at the University of Toronto. He holds the Tier 2 Canada Research Chair in Metabolic and Cognitive Health in Mental Illness. He is also the Medical Head for Clinical Research in the Schizophrenia Division and co-leads the Metabolic Clinic and the Clozapine Clinic at CAMH.
Areas of Research
Dr. Agarwal’s research interest lies in understanding the mechanisms underlying metabolic and cognitive dysfunction in mental illness with specific focus on insulin signaling in the brain. He also runs clinical trials to evaluate the efficacy of new treatments for these abnormalities. He has won several international research awards and his research program has been funded by federal, provincial, and local grant agencies.
Publications
View Dr. Agarwal's publications here.